The study's objective is to come up with a description of the international financial ecosystem surrounding the development of novel medicines (R&D). This entails charting the types of public and private players involved in research and development of medicines, ascertaining how the research agenda is prepared, establishing the strategies, mechanisms, incentives and drivers of the actors, including investors, as well as how national and international funding for new medicines (including investments and disinvestments, returns, etc.) is shaped.
Services
27/08/2020 10:00:00
73000000-2 Services de recherche et développement et services de conseil connexes
73110000-6 Services de recherche
73200000-4 Services de conseil en recherche et développement
79311400-1 Services de recherche économique
71620000-0 Services d'analyses
66170000-2 Services de conseils financiers, services de traitement des transactions financières et services de chambres de compensation
Avis | Date d'envoi |
---|---|
[TNV3F02ContractNotice] (TenderNed) | 29/04/2020 16:00 |
![]() |
24/06/2020 13:23 |
[TNV3F03ContractAwardNotice] (TenderNed) | 21/07/2021 16:30 |